亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

Early Detection of Colon Cancer

技术优势: Detection of increased copy number of the chromosome 20 region, either alone or in addition to pathology, could provide a more objective, reliable measure for adenocarcinoma and adenoma diagnosis and prognosis than pathology alone. The new methods may be particularly useful in the diagnosis of precursor states, which are often difficult to diagnose using traditional pathological methods but, unlike carcinomas, are uniformly curable.

技术应用: Diagnosis in humans: Detection of increased copy number of the chromosome 20 region in colon tissue polyps could be used to diagnose/confirm the stage and therefore the gravity of the lesion. Prognosis: The presence of increased copy number of the chromosome 20 region in high-grade dysplasia /intramucosal carcinoma lesions may be useful in predicting whether the lesions will have features similar to the invasive colon carcinomas. Thus, this assay could potentially become an important tool in decision-making for both surgery and therapy of those patients that have high-grade preadenomatous lesions. Research in the area of tumorigenesis. Drug discovery: Proteins coded by genes mapping to the chromosome 20 region that are differentially expressed in tumors having copy number alterations of this region may be candidate targets for tumor-specific drug development.

详细技术说明: Amplification of a region of human chromosome 20 is a frequent event in colon adenocarcinomas, occurring in approximately 70% of cases (or ~35%, when correction for chromosome 20 polysomy is applied). Researchers at the University of California have now found that intermediary diagnostic states of the adenoma to adenocarcinoma sequence that are thought to be the immediate precursors of adenocarcinoma, such as high-grade dysplasia and intramucosal carcinoma, also display increased copy number of this chromosomal region. Specifically, the researchers found amplifications of this region in approximately 40% (or ~30%, when correction for chromosome 20 polysomy is applied) of high-grade dysplasia lesions and intramucosal carcinomas. Methods of screening for colon carcinoma precursor cells by determining the presence of increased copy number of this region are covered by a U.S. patent assigned to the University of California (see below).

*Abstract: None

*IP Issue Date: Dec 4, 2001

*Principal Investigation: Name: Giovanni Pauletti
Department:

Name: Dennis Slamon
Department:

附加资料: Patent Number: US6326148B1
Application Number: US1999351763A
Inventor: Pauletti, Giovanni E. | Slamon, Dennis J.
Priority Date: 12 Jul 1999
Priority Number: US6326148B1
Application Date: 12 Jul 1999
Publication Date: 4 Dec 2001
IPC Current: C12Q000168
US Class: 43500618 | 435006
Assignee Applicant: The Regents of the University of California
Title: Detection of copy number changes in colon cancer
Usefulness: Detection of copy number changes in colon cancer
Summary: The method is used to screen for colon carcinoma cells in a sample and the findings are used to determine therapeutic treatment (claimed).
Novelty: Screening method for colon carcinoma precursor cells in a colorectal tissue sample by determining increased copy number of chromosome 20q using a hybridization probe

主要类别: 诊断/治疗

细分类别: 癌症/肿瘤

申请号码: 6326148

其他

BACKGROUND

Colorectal cancer is the second leading cause of cancer-related deaths and the third most common cancer in the US and other Western countries. Adenomatous polyps are well-known, clear-cut histologic lesions that have been identified as precursors to colorectal cancer. Therefore, polyps are of critical importance in the early identification and potential prevention of colorectal cancer. These pre-cancerous lesions are very common in the normal population, with frequencies of 30-40% in people 60 years and older. Fortunately, they can often be removed easily and in a time/cost effective way before they develop into actual cancers.

Polyps recur in a statistically significant subset of people who undergo polypectomy. Currently, there are no predictive factors to determine who will have recurrent polyps and eventually colon cancer among polypectomy patients, although people with high-grade polyps are believed to have a worse prognosis. As a consequence, the only method presently available for the diagnosis of colon lesions and determination of their prognosis is direct examination by a pathologist. This is a very approximate and subjective approach, however, and there is a need for markers that could help clinicians decide which high-grade polyps are more likely to become colorectal cancer.

Additional Technologies by these Inventors

Tech ID/UC Case

10155/1999-561-0

Related Cases

1999-561-0

国家/地区: 美国

欲了解更多信息，请点击这里